男人女人午夜视频免费,免费人妻无码不卡中文字幕系,国产A级三级三级三级,成年无码aⅴ片在线观看

心肌肌鈣蛋白T(TNNT2)檢測(cè)試劑盒(酶聯(lián)免疫吸附試驗(yàn)法)

ELISA Kit for Troponin T Type 2, Cardiac (TNNT2)

CMH2; cTnT; TnTc; Cardiomyopathy,Hypertrophic 2; Cardiac muscle troponin T

  • 心肌肌鈣蛋白T(TNNT2)檢測(cè)試劑盒(酶聯(lián)免疫吸附試驗(yàn)法)產(chǎn)品包裝(模擬)
  • 心肌肌鈣蛋白T(TNNT2)檢測(cè)試劑盒(酶聯(lián)免疫吸附試驗(yàn)法)產(chǎn)品包裝(模擬)
  • 心肌肌鈣蛋白T(TNNT2)檢測(cè)試劑盒(酶聯(lián)免疫吸附試驗(yàn)法)實(shí)驗(yàn)結(jié)果圖
  • SED232Hu.jpg標(biāo)準(zhǔn)曲線圖
  • Certificate通過(guò)ISO 9001、ISO 13485質(zhì)量體系認(rèn)證

特異性

本試劑盒用于檢測(cè)心肌肌鈣蛋白T(TNNT2),經(jīng)檢測(cè)與其它相似物質(zhì)無(wú)明顯交叉反應(yīng)。
由于受到技術(shù)及樣本來(lái)源的限制,不可能完成對(duì)所有相關(guān)或相似物質(zhì)交叉反應(yīng)檢測(cè),因此本試劑盒有可能與未經(jīng)檢測(cè)的其它物質(zhì)有交叉反應(yīng)。

回收率

分別于定值血清及血漿樣本中加入一定量的心肌肌鈣蛋白T(TNNT2)(加標(biāo)樣品),重復(fù)測(cè)定并計(jì)算其均值,回收率為測(cè)定值與理論值的比率。

樣本回收率范圍(%)平均回收率(%)
serum(n=5)93-105101
EDTA plasma(n=5)78-9881
heparin plasma(n=5)93-10197

精密度

精密度用樣品測(cè)定值的變異系數(shù)CV表示。CV(%) = SD/mean×100
批內(nèi)差:取同批次試劑盒對(duì)低、中、高值定值樣本進(jìn)行定量檢測(cè),每份樣本連續(xù)測(cè)定20 次,分別計(jì)算不同濃度樣本的平均值及SD值。
批間差:選取3個(gè)不同批次的試劑盒分別對(duì)低、中、高值定值樣本進(jìn)行定量測(cè)定,每個(gè)樣本使用同一試劑盒重復(fù)測(cè)定8次,分別計(jì)算不同濃度樣本的平均值及SD值。
批內(nèi)差: CV<10%
批間差: CV<12%

線性

在定值血清及血漿樣本內(nèi)加入適量的心肌肌鈣蛋白T(TNNT2),并倍比稀釋成1:2,1:4,1:8,1:16的待測(cè)樣本,線性范圍即為稀釋后樣本中心肌肌鈣蛋白T(TNNT2)含量的測(cè)定值與理論值的比率。

樣本1:21:41:81:16
serum(n=5)88-96%90-101%87-99%84-99%
EDTA plasma(n=5)80-93%81-91%86-101%95-105%
heparin plasma(n=5)98-105%80-92%92-104%79-105%

穩(wěn)定性

經(jīng)測(cè)定,試劑盒在有效期內(nèi)按推薦溫度保存,其活性降低率小于5%。
為減小外部因素對(duì)試劑盒破壞前后檢測(cè)值的影響,實(shí)驗(yàn)室的環(huán)境條件需盡量保持一致,尤其是實(shí)驗(yàn)室內(nèi)溫度、濕度及溫育條件。其次由同一實(shí)驗(yàn)員來(lái)進(jìn)行操作可減少人為誤差。

實(shí)驗(yàn)流程

1. 實(shí)驗(yàn)前標(biāo)準(zhǔn)品、試劑及樣本的準(zhǔn)備;
2. 加樣(標(biāo)準(zhǔn)品及樣本)100µL,37°C孵育1小時(shí);
3. 吸棄,加檢測(cè)溶液A100µL,37°C孵育1小時(shí);
4. 洗板3次;
5. 加檢測(cè)溶液B100µL,37°C孵育30分鐘;
6. 洗板5次;
7. 加TMB底物90µL,37°C孵育10-20分鐘;
8. 加終止液50µL,立即450nm讀數(shù)。

實(shí)驗(yàn)原理

將心肌肌鈣蛋白T(TNNT2)抗體包被于96孔微孔板中,制成固相載體,向微孔中分別加入標(biāo)準(zhǔn)品或標(biāo)本,其中的心肌肌鈣蛋白T(TNNT2)與連接于固相載體上的抗體結(jié)合,然后加入生物素化的心肌肌鈣蛋白T(TNNT2)抗體,將未結(jié)合的生物素化抗體洗凈后,加入HRP標(biāo)記的親和素,再次徹底洗滌后加入TMB底物顯色。TMB在過(guò)氧化物酶的催化下轉(zhuǎn)化成藍(lán)色,并在酸的作用下轉(zhuǎn)化成最終的黃色。顏色的深淺和樣品中的心肌肌鈣蛋白T(TNNT2)呈正相關(guān)。用酶標(biāo)儀在450nm波長(zhǎng)下測(cè)定吸光度(O.D.值),計(jì)算樣品濃度。

相關(guān)產(chǎn)品

編號(hào)適用物種:Homo sapiens (Human,人)應(yīng)用(僅供研究使用,不用于臨床診斷!)
RPD232Hu01心肌肌鈣蛋白T(TNNT2)重組蛋白Positive Control; Immunogen; SDS-PAGE; WB.
RPD232Hu03心肌肌鈣蛋白T(TNNT2)重組蛋白Positive Control; Immunogen; SDS-PAGE; WB.
RPD232Hu04心肌肌鈣蛋白T(TNNT2)重組蛋白Positive Control; Immunogen; SDS-PAGE; WB.
RPD232Hu02心肌肌鈣蛋白T(TNNT2)重組蛋白Positive Control; Immunogen; SDS-PAGE; WB.
APD232Hu01心肌肌鈣蛋白T(TNNT2)活性蛋白Cell?culture;?Activity?Assays.
PAD232Hu03心肌肌鈣蛋白T(TNNT2)多克隆抗體WB; IHC; ICC; IP.
PAD232Hu01心肌肌鈣蛋白T(TNNT2)多克隆抗體WB
PAD232Hu02心肌肌鈣蛋白T(TNNT2)多克隆抗體WB; IHC; ICC; IP.
LAD232Hu81心肌肌鈣蛋白T(TNNT2)多克隆抗體(異硫氰酸熒光素標(biāo)記)WB; IHC; ICC; IF.
LAD232Hu71心肌肌鈣蛋白T(TNNT2)多克隆抗體(生物素標(biāo)記)WB; IHC; ICC.
MAD232Hu23心肌肌鈣蛋白T(TNNT2)單克隆抗體WB; IHC
MAD232Hu29心肌肌鈣蛋白T(TNNT2)單克隆抗體IHC; FCM
MAD232Hu24心肌肌鈣蛋白T(TNNT2)單克隆抗體WB; IHC; FCM
MAD232Hu25心肌肌鈣蛋白T(TNNT2)單克隆抗體WB; IHC
MAD232Hu21心肌肌鈣蛋白T(TNNT2)單克隆抗體WB; IHC
MAD232Hu22心肌肌鈣蛋白T(TNNT2)單克隆抗體WB; IHC
MAD232Hu27心肌肌鈣蛋白T(TNNT2)單克隆抗體WB; IHC
MAD232Hu28心肌肌鈣蛋白T(TNNT2)單克隆抗體WB
FAD232Hu08抗心肌肌鈣蛋白T(TNNT2)單克隆抗體FCM
FAD232Hu02抗心肌肌鈣蛋白T(TNNT2)單克隆抗體Flow cytometry.
FAD232Hu04抗心肌肌鈣蛋白T(TNNT2)單克隆抗體Flow cytometry.
FAD232Hu06抗心肌肌鈣蛋白T(TNNT2)單克隆抗體Flow cytometry.
SED232Hu心肌肌鈣蛋白T(TNNT2)檢測(cè)試劑盒(酶聯(lián)免疫吸附試驗(yàn)法)Enzyme-linked immunosorbent assay for Antigen Detection.
HED232Hu心肌肌鈣蛋白T(TNNT2)檢測(cè)試劑盒(酶聯(lián)免疫吸附試驗(yàn)法,高敏型)Enzyme-linked immunosorbent assay for Antigen Detection.
MED232Hu心肌肌鈣蛋白T(TNNT2)檢測(cè)試劑盒(酶聯(lián)免疫吸附試驗(yàn)法,小樣本)Enzyme-linked immunosorbent assay for Antigen Detection.
SCD232Hu心肌肌鈣蛋白T(TNNT2)檢測(cè)試劑盒(化學(xué)發(fā)光免疫分析法)Chemiluminescent immunoassay for Antigen Detection.
LMD232Hu心肌肌鈣蛋白T(TNNT2)等多因子檢測(cè)試劑盒(流式熒光發(fā)光法)FLIA Kit for Antigen Detection.
KSD232Hu01心肌肌鈣蛋白T(TNNT2)檢測(cè)試劑盒DIY材料(酶聯(lián)免疫吸附試驗(yàn)法)自己動(dòng)手制作ELISA試劑盒的主要材料

參考文獻(xiàn)

雜志參考文獻(xiàn)
Basic & Clinical Pharmacology & ToxicologyCardioprotective Effect of Sulphonated Formononetin on Acute Myocardial Infarction in Rats[PubMed: 21232020]
Basic & Clinical Pharmacology & ToxicologyCardioprotective Effect of SMND-309, A Novel Derivate of Salvianolic Acid B on Acute Myocardial Infarction in Rats[Wiley: source]
European Journal of PharmacologyProtective roles of Asperosaponin VI, a triterpene saponin isolated from Dipsacus asper Wall on acute myocardial infarction in rats[ScienceDirect: S0014299909009984]
Journal of translational medicineThe altered expression profile of microRNAs in cardiopulmonary bypass canine models and the effects of mir-499 on myocardial ischemic reperfusion injury[PubMed: PMC3694448]
Oral Diseases Salivary high‐sensitivity cardiac troponin T levels in patients with acute myocardial infarction[Pubmed: 22834943]
An International Journal of Pharmaceutical SciencesIn vivo and in vitro cardioprotective effects of Panax quinquefolium 20 (S)-protopanaxadiol saponins (PQDS), isolated from Panax quinquefolium[Pubmed: 23700796]
Journal of Animal and Feed Sciences,The effects of caloric restriction and age on thyroid hormone signalling in the heart of rats[Pl:Source]
Liver Int.Cardiomyopathy reverses with recovery of liver injury, cholestasis and cholanemia in mouse model of biliary fibrosis[Pubmed:24330504]
Cardiovasc Toxicol. Cardioprotective Effect of Rhizomes of Acorus gramineus Against Isoproterenol-Induced Cardiac Damage in Pigs[Pubmed:24420420]
British Journal of PharmacologyGlutathione administration reduces mitochondrial damage and shifts cell death from necrosis to apoptosis in ageing diabetic mice hearts during exercise[Pubmed:25039894]
Chemico-Biological InteractionsCrocin protects against doxorubicin-induced myocardial toxicity in rats through down-reCavia (Guinea pig )lation of inflammatory and apoptic pathways[Pubmed:26807765]
The Journal of Pharmacology and Experimental TherapeutiesThe Cardenolide Glycoside Acovenoside A Affords Protective Activity in Doxorubicin-Induced Cardiotoxicity in Mice[Pubmed:27247000]
The Journal of Maternal-Fetal & Neonatal MedicineTroponins, heat shock proteins and glycogen phosphorylase BB in umbilical cord blood of complicated pregnancies.[pubmed:27937003]
PLoS One. Outer Balloon Ligation Increases Success Rate of Ischemia-Reperfusion Injury Model in Mice.[pubmed:27907155]
Biomedicine & PharmacotherapyRosuvastatin improves myocardial and neurological outcomes after asphyxial cardiac arrest and cardiopulmonary resuscitation in rats[pubmed:28076830]
PLoS OneImatinib attenuates cardiac fibrosis by inhibiting platelet-derived growth factor receptors activation in isoproterenol induced model[pubmed:28570599]
EXPERIMENTAL AND THERAPEUTIC MEDICINE Cardioprotective effect of Notch signaling on the development of myocardial infarction complicated by diabetes mellitus[pubmed:29042932]
PLoS OneIncreases in plasma corin levels following experimental myocardial infarction reflect the severity of ischemic injury[Pubmed: 30192780]
PLoS OneTissue suction-mediated gene transfer to the beating heart in mice[Pubmed: 32027678]
Journal of Human KineticsHormonal Response to Incremental and Continuous Exercise in Cyclists with Left Ventricle Hypertrophy[Pubmed: 32148580]
BIOMEDICINE & PHARMACOTHERAPYChlorogenic acid prevents acute myocardial infarction in rats by reducing inflammatory damage and oxidative stress[Pubmed: 33022535]
ToxicsNorepinephrine Leads to More Cardiopulmonary Toxicities than Epinephrine by Catecholamine Overdose in Rats[Pubmed: 32947820]
ElifeIron derived from autophagy-mediated ferritin degradation induces cardiomyocyte death and heart failure in mice[33526170]
Cell MetabolismPharmacological inhibition of arachidonate 12-lipoxygenase ameliorates myocardial ischemia-reperfusion injury in multiple species[34536344]
Anal Bioanal ChemDevelopment of a novel ssDNA aptamer targeting cardiac troponin I and its clinical applications[34673993]
Experimental and Therapeutic MedicineHydrogen therapy after resuscitation improves myocardial injury involving inhibition of autophagy in an asphyxial rat model of cardiac arrest[Pubmed:35495584]